Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005

Marya D. Zilberberg, Andrew F. Shorr, Marin H. Kollef

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Abstract

From 2000 through 2005, hospitalizations with resistant infections (methicillin-resistant Staphylococcus aureus, Clostridium difficile-associated disease, vancomycin-resistant enterococcus, Pseudomonas aeruginosa, and Candida infection) nearly doubled, from 499,702 to 947,393. Regional variations noted in the aggregate and by individual infection may help clarify modifiable risk factors driving these infections.

Original languageEnglish
Pages (from-to)1756-1758
Number of pages3
JournalEmerging Infectious Diseases
Volume14
Issue number11
DOIs
StatePublished - Nov 2008

Fingerprint Dive into the research topics of 'Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005'. Together they form a unique fingerprint.

Cite this